Related Experiment Video
Updated: Aug 22, 2026

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
Intracellular mechanisms mediating the anti-apoptotic action of gastrin
Saravanan Ramamoorthy1, Vinzenz Stepan, Andrea Todisco
1Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI, USA.
Abstract:
We previously reported that gastrin (G17) inhibits apoptosis of AR4-2J pancreatic adenocarcinoma cells, through the activation of Akt. We dissected the mechanisms responsible for this effect. D2, a CCKB receptor antagonist, inhibited G17 induction of Akt phosphorylation, measured by Western blots with anti-phospho-Akt antibodies. The intracellular calcium chelator BAPTA-AM, but not the PKC inhibitor GF109203X, blocked G17 induction of Akt. G17 stimulated BAD phosphorylation, measured by both Western blots with anti-phospho-BAD antibodies and by in vitro Akt kinase assays using recombinant BAD as substrate. G17 also induced FOXO3 phosphorylation assessed by Western blots with anti-phospho-FOXO3 antibodies, and BAPTA-AM inhibited this effect. Gastrin inhibited luciferase activity in cells transfected with FOXO1 together with a vector containing insulin-responsive sequences upstream of the luciferase reporter gene. In conclusion, G17 induces Akt through activation of CCKB receptors and of intracellular calcium-dependent, PKC-independent, pathways. This effect leads to BAD phosphorylation and to forkhead transcription factors inactivation.
Insights
Gastrin (G17) inhibits pancreatic cancer cell death by activating Akt. This occurs via CCKB receptors and calcium, leading to BAD and FOXO phosphorylation, ultimately inactivating transcription factors.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Gastrin (G17) previously shown to inhibit apoptosis in AR4-2J pancreatic adenocarcinoma cells.
- Akt signaling pathway implicated in gastrin's anti-apoptotic effect.
Purpose of the Study:
- To elucidate the molecular mechanisms by which gastrin (G17) inhibits apoptosis in pancreatic cancer cells.
- To identify the specific signaling pathways and molecules involved in gastrin-mediated Akt activation.
Main Methods:
- Western blotting to measure Akt, BAD, and FOXO3 phosphorylation.
- In vitro Akt kinase assays using recombinant BAD.
- Luciferase reporter assays to assess forkhead transcription factor activity.
- Use of CCKB receptor antagonist (D2) and calcium chelator (BAPTA-AM).
Main Results:
- D2 and BAPTA-AM blocked G17-induced Akt phosphorylation, indicating CCKB receptor and calcium dependence.
- G17 stimulated phosphorylation of BAD and FOXO3, key apoptosis regulators.
- G17 inhibited forkhead transcription factor activity in a calcium-dependent manner.
- PKC pathway was not involved in G17-induced Akt activation.
Conclusions:
- Gastrin (G17) inhibits apoptosis in pancreatic cancer cells by activating Akt.
- This activation is mediated by CCKB receptors and intracellular calcium, independent of PKC.
- Downstream effects include BAD and FOXO phosphorylation, leading to the inactivation of forkhead transcription factors.
Related Concept Videos
Gastritis II: Pathophysiology
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...

